The FDA approved the Vabysmo 6-mg single-dose prefilled syringe for the treatment of wet age-related macular degeneration, diabetic macular edema and macular edema following retinal vein occlusion ...

Trends, opportunities and forecast in prefilled syringe market to 2027 by material (glass-based and plastic-based), product type (conventional and safety), design (single chamber, dual chamber ...

The global prefilled syringe market is growing at a CAGR of 10.6% from 2022 to 2030.Pune, India, Nov. 10, 2023 (GLOBE NEWSWIRE) -- Prefilled syringes (PFS) are the most recent aids for ...

Heading into 2025, the chief item on argenx’s agenda is the FDA’s April 10 target action date to decide on the approval of a prefilled syringe version of Vyvgart—also known as efgartigimod ...

Fresh off earning FDA approval for a prefilled syringe version of Vyvgart Hytrulo for at-home administration, argenx is building buzz with a new direct-to-consumer campaign.. The “Treatment MY ...

Please provide your email address to receive an email when new articles are posted on . The European Medicines Agency approved the Vabysmo 6 mg prefilled syringe for three retinal conditions ...

Due to advances in technology and increased development of parenteral drugs, one of the fastest growing choices for drug delivery in the pharmaceutical industry is the prefilled syringe (PFS). Not ...

CSL Behring said on Tuesday that the U.S. Food and Drug Administration (FDA) approved a 50mL/10gm prefilled syringe for Hizentra (Immune Globulin Subcutaneous [Human] 20% Liquid).

The U.S. Food and Drug Administration (FDA) has approved Dutch biotech argenx’s (NASDAQ:ARGX) (OTCPK:ARGNF) autoimmune disease drug Vyvgart Hytrulo, developed with Halozyme Therapeutics (NASDAQ ...

ANI Pharmaceuticals Receives FDA Approval For Purified Cortrophin Gel Prefilled Syringe March 03, 2025 — 10:32 pm EST Written by RTTNews.com for RTTNews -> ...

The FDA’s latest approval of the therapy was based on data from studies evaluating the pre-filled syringe version’s bioequivalence to Vyvgart Hytrulo in a vial. Also supporting the decision were ...